70 studies found for:    Raynaud's
Show Display Options
Rank Status Study
21 Completed Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease
Condition: Raynaud's Disease
Interventions: Drug: SLx-2101;   Drug: Placebo
22 Completed Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome
Condition: Raynaud Syndrome
Interventions: Drug: vardenafil;   Drug: Placebo
23 Not yet recruiting Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon
Condition: Secondary Raynaud's Phenomenon
Intervention: Drug: Neovasculgen
24 Completed
Has Results
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
Condition: Raynaud Phenomenon
Intervention: Drug: Udenafil or Amlodipine
25 Recruiting Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
Conditions: Raynaud's Phenomenon;   Skin Necrosis
Interventions: Drug: Tracleer;   Drug: Prostavasin
26 Completed Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator
Condition: Raynaud Disease
Interventions: Drug: Riociguat (Adempas, BAY63-2521);   Drug: Placebo
27 Completed
Has Results
A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon
Conditions: Raynaud;   Scleroderma
Intervention: Drug: Fasudil
28 Completed
Has Results
Botulinum Toxin in the Treatment of Raynaud's
Condition: Raynaud's Syndrome
Intervention: Drug: botulinum toxin A
29 Unknown  Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
Condition: Raynaud Disease
Intervention: Drug: Ginkgo biloba extract EGb 761®
30 Completed St. John's Wort in the Treatment of Raynaud's Phenomenon
Condition: Raynaud's Disease
Interventions: Drug: St. John's Wort;   Drug: Lactose
31 Recruiting Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: atorvastatin;   Drug: Placebo
32 Completed Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction
Condition: Systemic Sclerosis
Intervention: Drug: Cialis
33 Recruiting PORH and Response to Cold in Raynaud's Phenomenon.
Conditions: Raynaud Disease;   Hyperemia;   Cold
Interventions: Procedure: post-occlusive hyperemia;   Procedure: cooling box;   Drug: L-NMMA and Fluconazole dermic injection
34 Completed Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
35 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis
Conditions: Systemic Sclerosis;   Raynaud Disease
Intervention: Drug: iloprost
36 Active, not recruiting A Two-Part Study of BOTOX® Therapy for Ischemic Digits
Condition: Raynaud's Disease
Intervention: Drug: onabotulinum toxin type-A
37 Active, not recruiting Metabolomic Analysis of Systemic Sclerosis
Conditions: Scleroderma (Limited and Diffuse);   Undifferentiated Connective Tissue Disease;   Raynaud Disease;   Vascular Disease;   Healthy Control Subjects
Intervention: Procedure: - Skin biopsy - Urine sample - Blood sample
38 Completed Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon
Condition: Raynaud's Disease
Intervention: Drug: Pletal
39 Completed Raynaud's Treatment Study (RTS)
Conditions: Cardiovascular Diseases;   Heart Diseases;   Raynaud's Disease;   Vascular Diseases
Interventions: Drug: nifedipine;   Behavioral: biofeedback (psychology);   Procedure: electromyography
40 Recruiting Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
Conditions: Primary Raynaud Disease;   Systemic Sclerosis
Intervention: Biological: soluble Ve cadherin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years